CELSUS THERAPEUTICS PLC's ticker is CLTX and the CUSIP is 15119A202. A total of 5 filers reported holding CELSUS THERAPEUTICS PLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 286,508 | $166,000 | 0.02% |
| MORGAN STANLEY | 8 | $0 | 0.00% |
| UBS Group AG | 3,350 | $2,000 | 0.00% |
| Citadel Advisors | 15,249 | $9,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 600 | $348,000 | 0.00% |